Semaglutide , is sold under the brand names Ozempic as well as Wegovy.
Tirzepatide, is sold under the brand name Mounjaro®,
These are two newest injectable drugs in a group of drugs called GLP-1 receptor agonists (or GLP-1 mimickers). Ozempic was FDA approved for the treatment of type 2 diabetes in December 2017 . Wegovy was FDA approved for the treatment of obesity in adults in June 2021. Mounjaro was FDA approved for the treatment of type 2 diabetes in May 2022 and is currently on fast track to be approved for weight loss. In addition to their effects on blood sugar and insulin levels, studies have shown that these medications provided substantial and sustained weight loss
Weight loss results will vary from person to person, but clinical studies have shown that Semaglutide can help to produce significant weight loss in overweight and obese individuals.
In clinical trials for Ozempic, participants lost an average of 13.5 pounds over 26 weeks when used in combination with moderate diet and exercise. In a 68-week study, participants taking Ozempic lost up to 20% of their body weight and those on Wegovy lost an average of 16.0% of their initial body weight, compared to 5.7% for those taking a placebo.
Mounjaro®(Tirzepatide) may result in (may vary depending on individuals & the dosing) better weight loss than Ozempic® and Wegovy (Semaglutides)
You need to carefully read the consent form along with information on risks and benefits. Although safety is our top priority and we make the best possible effort to make the medication achieve its intended goal with no or minimal side effects, however every patient is unique and if for any reason you experience severe nausea, abdominal discomfort or any allergic reaction ,please call us ASAP so we can initiate the appropriate treatment. If symptoms are severe you need to seek emergency helpby calling 911.
Although GLP-1 receptor agonists have been used in USA for the last 18 years Exenatide( Byetta), which was approved by the US Food and Drug Administration (FDA) in April 2005 for the treatment of T2DM& carry a stellar safety profile and multiple benefits besides weight loss including cardiaovascular benefits, like any pharmaceutical agent , any presently unknown long term post marketing side effects of the medications may surface in course of time. If such happens, Golden weight Loss will not be held liable for the damages.
If you carry a diagnosis of diabetes and would like us to take over your diabetic care, as long as your insurance cover the cost of the medication, our Doctor or Nurse practitioner can try to prescribe you one of the two medications ( Ozempic or Mounjaro) as long as you fit the right profile.
If you have a BMI 30 or above, (qualifying for obesity) and you have a commercial insurance that would cover the cost of the medication, we can see you for an office visit and try prescribing you Wegovy as long as you fit the right profile.
If you do not qualify for the above, we can still evaluate you medically and determine if compounded Ozempic , Mounjaro or Wegovy would be a good alternative for your medical needs.
We partner with certified compounding pharmacies that have Semaglutide or Tirzepatide either linked to l-carnitine or B12. If deemed medically appropriate for you, the doctor will prescribe you and it will be dispensed to you in our office and we will train you on administering self injection and storage.
Branded medications can be very costly if all is paid out of pocket costing approximately $275 per weekly pen.
If your insurance carrier cover it, it may cost as little as $25/ month to $500 a month when using the discount coupons offered by the Manufactures Novo Nordisk and Eili Lilly . The prescritions we write or send electronically will need to be redeemed , processed and filled at the pharmacy.
The doses of compounded SEMIGLUTIDE & Tirzepatide injections that we offer and dispense at our office range from $40 a dose ( $120/ month for 4 doses) to $160/dose($640/month for 4 doses)
This does includes our consultation (visit cost). You need to follow up at least once every 4 weeks.
Semiglutide &Tirzepatide are injected under the skin (subcutaneously) of your stomach, thigh, or upper arm. Use Mounjaro 1 time each week, at any time of the day). It is not necessary but advisable to (rotate) your injection site with each weekly injection. Do not use the same site for each injection
If you are not able to achieve your target weight with diet & exercise, please donot procrastinate seeking help. You can avoid or arrest obesity relalated complications, such as hypertension, diabetes, cardiovascular complications , Sleep Apnea, Arthritis of Hips & Knees etc.
Call us 310-955-4108 ( This number is for our Memphis, TN office)